Stock·NYSE·Financial Services
Brown & Brown Inc. (BRO)
- Market cap
- $23.22B
- P/E
- 20.23
- Dividend yield
- 0.95%
- Street target
- $74.00median of 20 analysts
- 52-week range
- $53.81 $90.46
The short version
Where BRO stands today, in four lines, and what CleaRank Financial AI makes of it.
BRO at a glance
Brown & Brown Inc. (BRO): Buy, 65/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($67.20 and $67.10).
- Earnings BRO beat estimates in 6 of its last 8 quarters, yet fell the next day after 5 of those beats.
- Insiders Insiders bought $505K and made no open-market sales over the last 18 months.
- Valuation P/E of 20.2 against 16.5 for the Financial Services sector: a premium to peers (+23%).
Figures as of October 18, 2026.
CleaRank Financial AI
CleaRank rates Brown & Brown Inc. (BRO) Buy, with a model score of 65/100.
Momentum lifts the score most: the 14-day RSI of 66.6 is in the bullish zone and the MACD line is positive. Valuation holds it back most: the P/E of 20.23 is 22.6% above the sector median (a premium to peers). The trend is up: BRO trades 3.27% above its 50-day average of $67.20 and 3.43% above its 200-day average of $67.10. Over the past year the price fell 20.61%.
Only on CleaRank
Figures we compute ourselves from BRO's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $69.40 is 3.3% above the 50-day simple moving average of $67.20.Price above its 200-day average ›
The price is 3.4% above the 200-day simple moving average of $67.10.50-day average above the 200-day ›
The 50-day average ($67.20) is 0.1% above the 200-day average ($67.10), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 43% of its 52-week range, between $53.81 and $90.46.
BRO share price
Pick a period: each tab shows how far BRO has moved over it, to the last close.
Today's trading
Where BRO sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 20.23 is 22.6% above the Financial Services median of 16.5.P/S below the sector median ›
The price-to-sales ratio of 3.41 is 10.2% below the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $1.2B on revenue of $6.7B, a net margin of 17.9%.Beat estimates in most recent reports ›
BRO beat the EPS estimate in 6 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 0.95%, or $0.66 a share a year.
Key statistics
The headline figures for BRO.
As of October 18, 2026, BRO trades at $69.40, with a market value of $23.22B, a P/E ratio of 20.23 and a dividend yield of 0.95%.
What the numbers say
CleaRank Financial AI's reading of BRO's valuation, growth and risks.
Against the 16.5 median P/E of Financial Services stocks, Brown & Brown Inc. (BRO)'s P/E of 20.23 is 22.6% above that median, which counts as a premium to peers. Measured against sales, the P/S of 3.41 is 10.3% below the sector median of 3.8. The company has a market value of $23.2B and trailing earnings of $3.36 a share.
Over the latest year, revenue grew 32.40%, running 20.7 percentage points ahead of the 11.7% sector median for Financial Services. The company converts this into a net margin of 18.08% and an operating margin of 41.84%. Return on equity stands at 10.02%, which is below the sector median of 13.8%. Debt-to-equity is 0.64, and the trailing dividend yield is 0.95%, or $0.66 a share per year.
In its last earnings report, on July 27, 2026, BRO posted $1.07 a share against a $1.07 estimate, coming in below the estimate by 0.00%. The stock still rose 5.67% in the next session.
Over its last 8 reports, BRO topped the estimate 6 times; even so, 5 of those 6 beats were followed by a lower share price the next session. The January 26, 2026 report stands out among the earlier ones: a beat of 3.33%, after which the stock fell 6.91%. Analysts' average EPS estimate for this fiscal year is $4.48, which would be growth of 5.2%, and $4.83 for next year (growth of 7.7%).
Valuation leaves less margin for error: the P/E of 20.23 is 22.6% above the sector median, a premium to peers. The 30-day standard deviation of BRO's daily returns is 2.06%. The price is 23.28% below its 52-week high of $90.46.
BRO against the Financial Services sector
How BRO compares with the median Financial Services stock CleaRank tracks.
Price to earnings vs sector: BRO trades at a significant premium to sector peers (+23%), suggesting market expectations for superior growth or market position.
Return vs XLF: Since May 6, 2025, BRO has lost 37.1% against a gain of 12.9% for XLF.
Performance against XLF
BRO and the Financial Services sector fund over the same days.
Revenue and earnings
How much BRO sells, and how much of it becomes profit.
Revenue growth: Revenue grew 22.5% in FY2025 to $5.8B, from $4.7B a year earlier.
Profit margin: The net margin was 18.5% in FY2025, down from 21.3% the year before.
Profitable: BRO earned $1.1B in FY2025.
Earnings reality check
Did BRO beat what analysts expected, and how did the stock react?
Earnings record: BRO beat the analyst estimate in 6 of the last 8 quarters.
Market reaction: The stock fell in the first session after 5 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 27, 2026after close | $1.07 | $1.07 | +0.00% | +5.67% | +2.98% |
| Apr 27, 2026after close | $1.36 | $1.39 | +2.21% | -4.51% | -12.83% |
| Jan 26, 2026after close | $0.90 | $0.93 | +3.33% | -6.91% | -10.45% |
| Oct 27, 2025after close | $0.93 | $1.05 | +12.90% | -6.13% | -11.33% |
| Jul 28, 2025after close | $0.99 | $1.03 | +4.04% | -10.40% | -9.63% |
| Apr 28, 2025after close | $1.30 | $1.29 | -0.77% | -6.00% | -3.90% |
| Jan 27, 2025after close | $0.77 | $0.86 | +11.69% | -2.61% | -2.13% |
| Oct 28, 2024after close | $0.88 | $0.91 | +3.41% | +1.64% | +2.03% |
As of October 18, 2026, BRO has beaten the analyst EPS estimate in 6 of its last 8 reported quarters and fell in the first trading session after 5 of those beats; its latest report, on July 27, 2026, came in 0.00% above the estimate and the stock moved +5.67% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 66.6, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 66.6 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of BRO
The score, the reasoning behind it, and what could move the price next.
BRO has an upward trend: the price of $69.40 sits 3.43% above its 200-day average of $67.10 and 3.27% above its 50-day average of $67.20. Because the 50-day average is 0.15% above the 200-day average, the shorter-term trend is pulling ahead of the longer one. Within its 52-week range, which runs from a low of $53.81 to a high of $90.46, the price stands at 43%.
Recent gains sit against a weaker longer record: the price rose 5.34% over the past month, rose 0.07% over the past three months and fell 20.61% over the past year. On momentum, the 14-day RSI reads 66.6, in the bullish zone, below the overbought line, with the MACD line positive.
Earnings miss ›
The July 27, 2026 report missed the EPS estimate by 0.00%, and the share price rose 5.67% in the first session after it.
Source: Earnings report, July 27, 2026
Rating reaffirmed ›
Mizuho kept its Outperform rating on October 7, 2026.
Source: Analyst action, Mizuho, October 7, 2026
- Two levels matter most: the 52-week high of $90.46 above the price, and the 50-day SMA at $67.20 below it.
- A 14-day RSI of 66.6 falls in the bullish zone, and the MACD line is positive. Readings above 70 or below 30 point to stretched momentum.
- In the first session after the July 27, 2026 report, the share price rose 5.67%. Over the last 8 reports, BRO beat estimates in 6.
BRO trades above its 50-day and 200-day moving averages ($67.20 and $67.10), which is what makes the trend up; losing the 50-day would be the first warning. The nearest level under the price is the 50-day SMA at $67.20.
The next level above the price for BRO is the 52-week high of $90.46. The RSI is in the bullish band, which backs the current direction, though it is near the overbought threshold.
Technical indicators
Momentum and trend for BRO, from its daily closes.
As of October 18, 2026, with BRO at $69.40, its 14-day RSI is 66.6 (showing bullish momentum without being overbought), its 50-day simple moving average is $67.20 and its 200-day is $67.10.
Calculated by CleaRank on daily closes as of October 18, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What BRO moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 18, 2026, BRO's 1-year correlation of daily returns is +0.10 with S&P 500 (SPY), -0.07 with Nasdaq 100 (QQQ), -0.02 with Bitcoin (BTC) and -0.07 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
5 of 20 analysts rate it a buy or strong buy, 14 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $74.00 is 6.6% above the price.More buy ratings than three months ago ›
5 of 20 rate it a buy now, against 4 of 19 three months ago.
BRO Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 7, 2026 | Mizuho | Maintains | Outperform |
| Oct 7, 2026 | Barclays | Maintains | Equal-Weight |
| Oct 6, 2026 | Morgan Stanley | Maintains | Underweight |
| Oct 1, 2026 | JP Morgan | Maintains | Neutral |
| Sep 16, 2026 | Mizuho | Maintains | Outperform |
| Aug 19, 2026 | Morgan Stanley | Maintains | Underweight |
As of October 18, 2026, 20 Wall Street analysts cover BRO: 5 rate it a buy or strong buy, 14 a hold and 1 a sell or strong sell. Their 12-month price targets range from $55.00 to $90.00, with a median of $74.00, 6.6% above the price of $69.40.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
BRO trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from BRO's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much BRO tends to move, against the market and on its own.
The long record
BRO's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 2.06% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 54.6%, from April 2025 to May 2026; the price is still 43.4% below that peak.Most 1-year holds ended higher ›
79% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $40,517, against $41,793 in the S&P 500 (SPY).
BRO Drawdowns & Recovery
As of October 18, 2026, BRO's worst peak-to-trough fall over the last 10 years with dividends reinvested was -54.6% (April 2025 to May 2026); it is still 43.4% below that peak, and 79% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into BRO in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: BRO trailed the S&P 500 over this period: $40,517 against $41,793.
A $10,000 investment in BRO in October 2016 would be worth about $40,517 today with dividends reinvested, compared with about $41,793 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to BRO, and which have not.
Strongest month, November: an average of +6.26%, up in 10 of 10 years.
Weakest month, September: an average of -3.25%, up in 2 of 10 years.
This month, October: has averaged -1.24%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, BRO's strongest calendar month has been November (average +6.26%, up in 10 of 10 years) and its weakest September (average -3.25%, up in 2 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in BRO, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in BRO today could grow to about $23,643 by 2036 in the base case, with a 90th-percentile outcome near $63,580 and a 10th-percentile outcome around $8,792. The simulation models price only; at today's 0.95% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
BRO Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $97.91 for BRO by 2030 in the base case, from $69.40 today (1.4x over 4 years). The 10th-percentile path ends near $52.38. These are outcomes of a Monte Carlo simulation run on BRO's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $55.32 | $75.64 | $103 | |
| 2028 | $52.96 | $82.43 | $128 | |
| 2029 | $52.26 | $89.84 | $154 | |
| 2030 | $52.38 | $97.91 | $183 | |
| 2031 | $53.02 | $107 | $215 |
Method: a lognormal simulation of BRO's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
BRO insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $505K on the open market.
As of October 18, 2026, BRO insiders reported no open-market sales and 4 open-market purchases worth $505K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | James S Hunt
Director
|
Grant | 5.0K | - |
| Jun 9, 2026 | Joia M Johnson
Director
|
Buy | 860 | $49.9K |
| May 6, 2026 | Lawrence L Gellerstedt III
Director
|
Grant | 2.4K | - |
| May 6, 2026 | Theodore J Hoepner Jr
Director
|
Grant | 2.4K | - |
| May 6, 2026 | James S Hunt
Director
|
Grant | 2.4K | - |
| May 6, 2026 | Toni Jennings
Director
|
Grant | 2.4K | - |
| May 6, 2026 | Joia M Johnson
Director
|
Grant | 2.4K | - |
| May 6, 2026 | Paul J Krump
Director
|
Grant | 2.4K | - |
| May 6, 2026 | Timothy R M Main
Director
|
Grant | 2.4K | - |
| May 6, 2026 | Bronislaw Edmund Masojada
Director
|
Grant | 2.4K | - |
| May 6, 2026 | Jaymin B Patel
Director
|
Grant | 2.4K | - |
| May 6, 2026 | H Palmer Proctor Jr
Director
|
Grant | 2.4K | - |
| May 6, 2026 | Wendell S Reilly
Director
|
Grant | 2.4K | - |
| May 6, 2026 | Kathleen A Savio
Director
|
Grant | 2.4K | - |
| May 5, 2026 | H Palmer Proctor Jr
Director
|
Buy | 2.0K | $114.2K |
| Feb 26, 2026 | Stephen M. Boyd
Officer
|
Grant | 16.1K | - |
| Feb 26, 2026 | James Powell Brown
Chief Executive Officer
|
Grant | 95.9K | - |
| Feb 26, 2026 | P Barrett Brown
Officer
|
Grant | 13.0K | - |
| Feb 26, 2026 | Paul M Gallagher
Officer
|
Grant | 1.1K | - |
| Feb 26, 2026 | Stephen Patrick Hearn
Officer
|
Grant | 7.1K | - |
| Feb 26, 2026 | Jerome Scott Penny
Officer
|
Grant | 15.7K | - |
| Feb 26, 2026 | Julie Turpin
Officer
|
Grant | 14.6K | - |
| Feb 26, 2026 | Chris Lee Walker
Officer
|
Grant | 15.1K | - |
| Feb 26, 2026 | R Andrew Watts
Chief Financial Officer
|
Grant | 32.1K | - |
| Dec 31, 2025 | P Barrett Brown
Officer
|
Grant | 127.0K | - |
| Dec 19, 2025 | R Andrew Watts
Chief Financial Officer
|
Grant | 3.6K | - |
| Dec 17, 2025 | Stephen M. Boyd
Officer
|
Grant | 1.5K | - |
| Dec 15, 2025 | J. Hyatt Brown
Chairman of the Board
|
Grant | 1.4K | - |
| Aug 8, 2025 | Paul J Krump
Director
|
Buy | 2.7K | $249.9K |
| Aug 6, 2025 | Bronislaw Edmund Masojada
Director
|
Buy | 1.0K | $91.4K |
| May 7, 2025 | Lawrence L Gellerstedt III
Director
|
Grant | 1.3K | - |
| May 7, 2025 | Theodore J Hoepner Jr
Director
|
Grant | 1.3K | - |
| May 7, 2025 | James S Hunt
Director
|
Grant | 1.3K | - |
| May 7, 2025 | Toni Jennings
Director
|
Grant | 1.3K | - |
| May 7, 2025 | Paul J Krump
Director
|
Grant | 1.3K | - |
| May 7, 2025 | Timothy R M Main
Director
|
Grant | 1.3K | - |
| May 7, 2025 | Bronislaw Edmund Masojada
Director
|
Grant | 1.3K | - |
| May 7, 2025 | Jaymin B Patel
Director
|
Grant | 1.3K | - |
| May 7, 2025 | H Palmer Proctor Jr
Director
|
Grant | 1.3K | - |
| May 7, 2025 | Wendell S Reilly
Director
|
Grant | 1.3K | - |
| May 7, 2025 | Kathleen A Savio
Director
|
Grant | 1.3K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 18, 2026.